5 unknown, 4 completed, 2 recruiting, 1 active not recruiting. 4 Not applicable, 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 1 | 4 | Unknown 2, Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ovarian Tumor: new trials by email Literature Review of Ovarian Tumor trials Research Report on Ovarian Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery Ovarian Cancer, Ovarian Tumor | Not yet recruiting | Catharina Ziekenhuis Eindhoven | 1300 | 2026-11-01 | 2026-10-20 | |
| Effect of Hypnosis in the Management of Anxiety and Chemo-induced Symptoms in Adolescents and Young Adults With Sarcoma or Germ Cell Tumor and in Young Women With Breast Cancer HYPNOSIS - Sarcoma, Germ Cell Tumor of Testis | Not applicable | Recruiting | Institut Bergonié | 70 | 2026-09-15 | 2026-09-22 |
| Prospective RegIstration Of the peRformance of the IoTa ADNEX Model in Dutch gYnaecological Practice Observational study. Prospective registration of ultrasound data in patients with ovarian tumors for which an ultrasound in according with the IOTA definitions is performed. - Ovarian Tumor, Ovarian Cancer | Recruiting | Maxima Medical Center | 613 | 2022-07-15 | 2023-10-27 | |
| A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors DS-6000a - Renal Cell Carcinoma, Ovarian Tumor | Phase 1 | Active not recruiting | Daiichi Sankyo | 179 | 2020-12-22 | 2026-09-04 |
| The Application of Real-Time Near-infrared Imaging in Gynecological Surgery Intravenous ICG and Real-Time Near-infrared Imaging - Cervical Cancer, Ovarian Tumor | Not applicable | Unknown | Chen Chunlin | 500 | 2020-01-01 | 2020-01-14 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso anti-meso-CAR vector transduced T cells - Malignant Mesothelioma, Pancreatic Cancer | Phase 1 | Unknown | Chinese PLA General Hospital | 20 | 2015-10-01 | 2015-10-20 |
| Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 anti-CD133-CAR vector-transduced T cells - Liver Cancer, Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Chinese PLA General Hospital | 20 | 2015-06-01 | 2019-12-17 |
| Prospective Multicenter Study in Patients With a Tumor Benign Ovarian Presumed on the Use of Algorithms Such as Roma and RMI and Tumor Markers Such as CA125 and HE4 Ovarian Tumor, Ovarian Cancer | Completed | Centre Hospitalier Departemental Vendee | 221 | 2015-05-01 | 2025-12-02 | |
| EURAD MRI Classification of US Indeterminate Adnexa Lesions ADNEXMR SCORING system - Ovarian Tumor | Completed | University of Wisconsin, Madison | 1340 | 2014-02-01 | 2020-03-26 | |
| EURAD-MR Classification : European Multicenter Study Ovarian Tumor | Unknown | Société d'Imagerie de la Femme | 1340 | 2013-03-01 | 2017-07-26 | |
| A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer DOXIL/CAELYX, ATI-0918 - Ovarian Cancer, Malignant Female Reproductive System Neoplasm | Phase 1 | Unknown | Azaya Therapeutics, Inc. | 40 | 2012-10-01 | 2015-01-15 |
| Assess Cancer in Ovarian Tumors With Biomarkers. Blood Draw - Ovarian Tumor | Not applicable | Completed | Ciphergen Biosystems | 1000 | 2007-02-01 | 2008-04-30 |
| Contrast-Enhanced Ultrasound Ability in the Characterization of Ovarian Masses Contrast-enhanced ultrasound - Ovarian Tumor | Not applicable | Unknown | University Hospital, Tours | 100 | 2002-09-01 | 2007-11-22 |
Ovarian Neoplasms (13) · Breast Neoplasms (2) · Endometrial Neoplasms (2) · Neoplasms (2) · Pancreatic Neoplasms (2) · Adenomyosis (1) · Arachnodactyly (1) · Brain Neoplasms (1) · Carcinoma, Renal Cell (1) · Colorectal Neoplasms (1) · Endometriosis (1) · Leukemia, Lymphoid (1) · Liver Neoplasms (1) · Mesothelioma, Malignant (1) · Neovascularization, Pathologic (1)
Adnexal Diseases (13) · Endocrine Gland Neoplasms (13) · Endocrine System Diseases (13) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Genital Diseases (13) · Genital Diseases, Female (13) · Genital Neoplasms, Female (13) · Gonadal Disorders (13) · Neoplasms by Site (13) · Ovarian Diseases (13) · Urogenital Diseases (13) · Urogenital Neoplasms (13) · Neoplasms (11) · Neoplasms by Histologic Type (4)
Blood Specimen Collection (1) · Doxorubicin (1) · Hypnosis (1) · liposomal doxorubicin (1)
Chinese PLA General Hospital (2) · Azaya Therapeutics, Inc. (1) · Catharina Ziekenhuis Eindhoven (1) · Centre Hospitalier Departemental Vendee (1) · Chen Chunlin (1) · Ciphergen Biosystems (1) · Daiichi Sankyo (1) · Institut Bergonié (1) · Maxima Medical Center (1) · Société d'Imagerie de la Femme (1) · University Hospital, Tours (1) · University of Wisconsin, Madison (1)
France (4) · United States (4) · China (3) · Netherlands (2) · Austria (1) · Belgium (1) · Canada (1) · Croatia (1) · Italy (1) · Japan (1) · Portugal (1) · Serbia (1) · Switzerland (1) · United Kingdom (1)
Andrea Rockall, MD (2) · Isabelle Thomassin-Naggara, MD, PhD (2) · Elizabeth Sadowski, MD (1) · Eric Fung, M.D. (1) · Fred Ueland, M.D. (1) · Gillian Crutcher (1) · Henri Marret, PR (1) · Jurgen Piek, M.D., Ph.D. (1) · Marc Bazot, MD (1)
PMID 25199746, PMID 26394736, PMID 28057014, PMID 28950327, PMID 29290809, PMID 29551477, PMID 29935649, PMID 31325591, PMID 31699959, PMID 31977064, PMID 33312759, PMID 35230183, PMID 35230489, PMID 36450938